SANTEN PHARMACEUTICAL CO., LTD.

4536・Prime Market・Pharmaceuticals

Official website

SANTEN PHARMACEUTICAL CO., LTD.

4536・Prime Market・Pharmaceuticals

Official website

SANTEN PHARMACEUTICAL CO., LTD.4536

Reference Indicators

Market Cap

6,518¥100M

P/E (Forecast)

16.3x

P/B

2.2x

Dividend Yield (Forecast)

2.08%

ROE

12.6%

EV/EBITDA

8.6x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	266,257	279,037	301,965	300,004	291,624
Cost of Sales	109,671	112,950	123,256	128,977	121,881
Gross Profit	156,586	166,087	178,709	171,027	169,743
SG&A Expenses	84,499	96,257	91,529	87,967	89,570
Operating Income	35,886	-3,090	38,541	46,880	47,797
Pre-tax Income	35,616	-5,799	29,874	47,481	47,442
Income Taxes	8,427	9,184	3,171	11,628	9,881
Net Income	27,218	-14,948	26,642	36,256	37,369
EBITDA	52,941	14,159	56,719	64,828	66,155
Gross Margin	58.8%	59.5%	59.2%	57.0%	58.2%
Operating Margin	13.5%	-1.1%	12.8%	15.6%	16.4%
ROA	5.9%	-3.5%	6.1%	8.9%	8.8%
ROE	8.1%	-5.1%	8.7%	12.7%	12.6%